CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
2.225
-0.095 (-4.09%)
At close: Oct 26, 2026, 4:00 PM EDT
2.260
+0.035 (1.57%)
After-hours: Oct 26, 2026, 7:55 PM EDT
CytomX Therapeutics Market Cap
CytomX Therapeutics has a market cap or net worth of $484.83 million as of October 26, 2026. It is the 14,712th most valuable company in the world and the 2,752nd biggest in the United States. Its market cap has decreased by 9.82% in one year.
Market Cap
484.83M
Enterprise Value
160.25M
1-Year Change
-9.82%
Global Rank
Country Rank
#2,752 United States
Category
ChartMarket Cap Chart
Since October 8, 2015, CytomX Therapeutics's market cap has increased from $7.40M to $484.83M, an increase of 6,451.70%. That is a compound annual growth rate of 45.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 484.80M | -32.83% |
| Dec 31, 2025 | 721.80M | 795.53% |
| Dec 31, 2024 | 80.60M | -22.35% |
| Dec 29, 2023 | 103.80M | -1.80% |
| Dec 30, 2022 | 105.70M | -62.58% |
| Dec 31, 2021 | 282.50M | -6.70% |
| Dec 31, 2020 | 302.80M | -19.81% |
| Dec 31, 2019 | 377.60M | -44.44% |
| Dec 31, 2018 | 679.60M | -16.18% |
| Dec 29, 2017 | 810.80M | 102.65% |
| Dec 30, 2016 | 400.10M | -46.78% |
| Dec 31, 2015 | 751.80M | 10,059.46% |
| Oct 8, 2015 | 7.40M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Crescent Biopharma | 548.71M |
| Electra Therapeutics | 546.70M |
| Bright Minds Biosciences | 516.67M |
| Entera Bio | 507.85M |
| Valneva SE | 493.97M |
| Oculis Holding AG | 487.68M |
| Indaptus Therapeutics | 485.32M |
| Arvinas | 477.32M |